To receive a quote for your preclinical trial or study, please contact a member of our sales team:
After a Non-Disclosure Agreement (NDA) is in place, your Surpass contact will request a description of proposed research, and will set up a meeting with members of the Surpass Research team as necessary for further discussion and questions. Following this discussion, a detailed proposal, including a quote, will be provided to you.
An Institutional Animal Care and Use Committee (IACUC) document must be completed and approved for any work involving live animals. Surpass can schedule your project as quickly as resources allow, and will work with you to put the appropriate IACUC documentation in place. We understand how scheduling can impact project timelines, so will work with you to complete your high quality research as efficiently as possible.
To ensure appropriate time for review by our committee, we ask that IACUC documents be submitted two weeks in advance of a study. Our scientists will assist you in answering any questions around this process. Please contact Surpass to discuss accelerated project needs.
To schedule a quality audit, please notify your sales contact or call the head of quality assurance:
Surpass welcomes our sponsors' physician advisors to participate in studies. Written qualifications and/or a CV must be provided to the Surpass IACUC in advance of the project for approval.
Surpass welcomes individuals with appropriate training and experience to participate in studies. Written qualifications and/or a CV must be provided to the Surpass IACUC in advance of the project for approval.
Surpass has years of experience conducting GLP preclinical studies for regulatory submissions and IRB approval, and provides qualified study directors and on-site veteran quality assurance auditing to ensure the success of your study. See GLP Services for more information.
Contact our sales team: